Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Stoll

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Immunology|March 29, 2002
Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designsChristine Galustian, Robert A Childs, Mark Stoll, et al.
Glycobiology|December 21, 2016
The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based dataYan Liu, Ryan McBride, Mark Stoll, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Immunology|March 29, 2002
Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designsChristine Galustian, Robert A Childs, Mark Stoll, et al.
Glycobiology|December 21, 2016
The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based dataYan Liu, Ryan McBride, Mark Stoll, et al.
Pageof 1